KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $3.5 million.

  • Zimmer Biomet Holdings' Gains from Investment Securities changed N/A to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 9441.34%. This contributed to the annual value of $5.4 million for FY2024, which is 1366.34% down from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Gains from Investment Securities stood at $3.5 million.
  • In the past 5 years, Zimmer Biomet Holdings' Gains from Investment Securities ranged from a high of $66.0 million in Q2 2023 and a low of -$73.3 million during Q3 2023
  • Moreover, its 5-year median value for Gains from Investment Securities was $3.5 million (2025), whereas its average is $6.0 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 1180000.0% in 2022, then tumbled by 208108.11% in 2023.
  • Zimmer Biomet Holdings' Gains from Investment Securities (Quarter) stood at $35.1 million in 2021, then crashed by 181.2% to -$28.5 million in 2022, then rose by 23.51% to -$21.8 million in 2023, then skyrocketed by 87.16% to -$2.8 million in 2024, then skyrocketed by 225.0% to $3.5 million in 2025.
  • Its Gains from Investment Securities stands at $3.5 million for Q3 2025, versus $300000.0 for Q1 2025 and -$2.8 million for Q4 2024.